Official 2024 U.S. DOL Form 5500 summary for Tarsus Pharmaceuticals, INC. (Tarsus Pharmaceuticals Retirement Plan · EIN 81-4717861 · PN 001): $24.88M net assets, 323 active participants, and Sponsor-paid or unbenchmarked.
| Plan Sponsor | Tarsus Pharmaceuticals, INC. |
|---|---|
| Filing Identifier | Tarsus Pharmaceuticals Retirement Plan · EIN 81-4717861 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (CA) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $24.88M |
| Active Participants | 323 |
| Direct Admin Fee Rate | Sponsor-paid or unbenchmarked |
| Cohort Peer Median | N/A |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($1.52M, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI